Medifast Posts 27.6% EPS Beat and $75.1M Q4 Revenue
Medifast reported an adjusted Q4 loss of $0.55 per share, beating consensus by $0.21 and delivering a 27.6% earnings surprise. Quarterly revenue of $75.1 million topped estimates by 6.1% but declined 37% from $119 million in the prior year.
1. Q4 Financial Results
Medifast posted an adjusted loss of $0.55 per share for Q4, outpacing the consensus estimate of a $0.76 loss and delivering a 27.6% earnings surprise. Revenue reached $75.1 million, surpassing forecasts by 6.1% but falling 37% from $119 million a year earlier.
2. Year-Over-Year Trends
The adjusted loss compares with earnings of $0.10 per share a year earlier, resulting in two EPS beats and two misses over the past four quarters. Revenue fell 37% year-over-year, underscoring challenges in sales volume.
3. Analyst Estimates and Outlook
Analysts forecast a Q1 adjusted loss of $0.12 per share on $67.12 million in revenue and a full-year adjusted loss of $0.57 on $228.38 million in revenue. These estimates will be revised following management’s commentary on the upcoming earnings call.